Background: Although CKD is said to increase among older adults, epidemiologic data on kidney function in people !70 years of age are scarce. The Berlin Initiative Study (BIS) aims to fill this gap by evaluating the CKD burden in older adults. Methods: The BIS is a prospective population-based cohort study whose participants are members of Germany's biggest insurance company. This cross-sectional analysis (i) gives a detailed baseline characterization of the participants, (ii) analyses the representativeness of the cohort's disease profile, (iii) assesses GFR and albuminuria levels across age categories, (iv) associates cardiovascular risk factors with GFR as well as albuminuria and (v) compares means of GFR values according to different estimating equations with measured GFR. Results: A total of 2069 participants (52.6% female, mean age 80.4 years) were enrolled: 26.1% were diabetic, 78.8% were on antihypertensive medication, 8.7% had experienced a stroke, 14% a myocardial infarction, 22.6% had cancer, 17.8% were anaemic and 26.5% were obese. The distribution of comorbidities in the BIS cohort was very similar to that in the insurance 'source population'. Creatinine and cystatin C as well as the albumin:creatinine ratio (ACR) increased with increasing age. After multivariate adjustments, reduced GFR and elevated ACR were associated with most cardiovascular risk factors. The prevalence of a GFR <60 mL/min/1.73 m 2 ranged from 38 to 62% depending on the estimation equation used. Conclusions: The BIS is a very well-characterized, representative cohort of older adults. Participants with an ACR !30 had significantly higher odds for most cardiovascular risk factors compared with an ACR <30 mg/g. Kidney function declined and ACR rose with increasing age.
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I N T R O D U C T I O N
Older adults account for the largest and still increasing proportion of those with decreased kidney function, a phenomenon that might also be fuelled by an ongoing demographic shift in most industrialized countries. Despite these increasing numbers of older individuals with decreased GFR, questions regarding its cause, progression and associated risk factors remain unanswered [1] . In addition, the clinical meaning of an agedependent loss of kidney function [2, 3] has been debated in recent years [4, 5] . Ironically, despite the obvious need for research in this area, elderly persons are in general highly underrepresented in clinical and epidemiological studies. One major reason might be that mobilization and recruitment remain a challenge [6] [7] [8] . One specific difficulty compared with research with younger individuals is that older age is often accompanied by a vulnerable state of health and an overall frailty that can complicate recruitment and retention immensely. This underrepresentation is also reflected in the literature by often incomplete or fragmentary data regarding lifestyle variables and comorbidities in older individuals, since in most surveys or cohort studies older individuals are not the main focus but constitute the upper tail of a much younger study population. Also, in the majority of cases prevalence rates of classic risk factors in combination with the assessment of GFR and albuminuria are not available.
The Berlin Initiative Study (BIS) is the only worldwide population-based elderly cohort focusing primarily on the epidemiology of CKD in geriatric nephrology, aiming to capture the burden, i.e. prevalence and incidence of CKD, as well as associated risk factors and the natural course of kidney function over time. After finishing recruitment of 2069 participants in 2011, this work gives a thorough cross-sectional baseline cohort profile, exploring sociodemographic and -economic characteristics, risk factors and nephrologic outcome variables in a vulnerable population >70 years of age. The analyses focus on the representativeness of the cohort, on eGFR and albuminuria levels stratified by age, the cross-sectional associations between kidney parameters and cardiovascular risk factors and differences in GFR results as a function of the GFR equations used.
M A T E R I A L S A N D M E T H O D S

Subjects and design
The BIS is a prospective, longitudinal, population-based cohort study that started its baseline visits in November 2009, enrolling 2069 participants !70 years of age through June 2011. The detailed study design can be found elsewhere [9] . The cross-sectional analysis of the baseline parameters with special emphasis on renal characteristics is the focus of this work. Two sampling methods for recruitment were used. Supported by Berlin's largest statutory health insurance company, the 'Allgemeine Ortskrankenkasse' (AOK)-Nordost (coverage is almost 50% of all individuals > 70 years of age living in Berlin), a random sample of insured individuals was selected for participation. In a fractionated manner (12 waves), invitation letters were sent to a total of 16 701 potential participants offering them a free kidney check-up at 1 of 13 study sites (nephrology practices or outpatient clinics) evenly distributed across the city of Berlin. Recipients could call a free hotline to arrange an appointment. Sampling was stratified for age (70-74, 75-79, 80-84, 85-89, !90 years) and gender. Also, individuals who had read a promotion article in their insurance company's health magazine and who fulfilled the inclusion criteria could call the same hotline for an appointment (advertisement sample).
Inclusion criteria were AOK membership and age !70 years. Dialysis and kidney transplant patients as well as nursing cases were excluded. Trained medical personnel answered the hotline and coordinated appointments.
The study visit included a standardized computer-based questionnaire asking about demographics, lifestyle variables, comorbidities and medication, as well as assessing anthropometric data. Measurements were carried out according to prespecified standardized operating procedures. Blood and urine samples were taken for instant analysis and for biobanking at À80
C. Prior to the study, written informed consent was obtained from all participants. The study was approved by the ethics committee of Charité Universit€ atsmedizin, Berlin, Germany.
Variables
The standardized interview included (i) sociodemographic factors; (ii) socio-economic status (income and education) and (iii) risk factors such as blood pressure (mean of two measurements), body mass index (BMI, <30/!30), waist:hip ratio (WHR), smoking (ever), alcohol intake (at least one glass per day, in categories), diabetes mellitus (intake of antidiabetic medication and/or HbA1c level >6.5%, yes/no), arterial hypertension (intake of antihypertensive medication), myocardial infarction, stroke, cancer (all self-reported, yes/no) and anaemia (haemoglobin, men <13 g/dL, women <12 g/dL). Exact medication was coded using the Anatomical Therapeutic Chemical (ATC) code [10] .
Outcome variables were eGFR and albuminuria values. GFR was estimated by five creatinine-based, two cystatin C-based and two combined creatinine/cystatin C-based equations: the four-variable Modification of Diet in Renal Disease (MDRD) Study [11] , CKD-EPI (crea) [12] , revised Lund-Malmö [13] , Cockcroft-Gault [14] and BIS1 [15] equations; the CAPA [16] and CKD-EPI (cysC) equations [17] ; the CKD-EPI (crea-cysC) [17] and BIS2 equations [15] (listed in detail in Supplementary data). GFR results were analysed in two (</!60 mL/min/1.73 m 2 ) and three categories (!60, 30-59, <30 mL/min/1.73 m 2 ). Albuminuria was defined as no (<30 mg/g creatinine), micro (30-299 mg/g) and macro (!300 mg/g).
Laboratory methods
All serum creatinine samples were analysed at Synlab (Heidelberg, Germany) using the isotope dilution mass spectrometry (IDMS) traceable enzymatic method 'creatinine plus cobas' on the Modular P800 System (Roche). The interassay coefficients of variation for serum creatinine were 2.3 and 3.4% at mean concentrations of 0.99 and 3.75 mg/dL, respectively. Cystatin C was measured at Labor Limbach (Heidelberg) using the particle-enhanced nephelometric (PENIA) N Latex assay on the BN II System (Siemens Health Care Diagnostics, Marburg, Germany). The Siemens cystatin C assay has been restandardized according to ERM-DA471/IFCC for BN systems. This standardized assay has been available since 2010 and minimizes the variations in cystatin C calibrators and harmonizes methods for the determination of cystatin C concentration. The interassay coefficients of variation for serum cystatin C were 3.4 and 4.6% at concentrations of 1.13 and 2.29 mg/L, respectively. Urinary albumin was measured immunologically and urinary creatinine by enzymatic assay, both on a Roche/Hitachi Modular P analyzer, to calculate the urinary albumin:creatinine ratio (ACR; in mg/g).
Protocol of iohexol measurement for measured GFR
Additionally, in a subgroup of 570 of the 2069 baseline participants, we performed iohexol plasma clearance for exact measurement of GFR. The methodology used to measure GFR has been described elsewhere [15, 18] and is presented in the Appendix in more detail. Briefly, iohexol solution (5 mL, 3235 mg; Accupaque, GE Healthcare Buchler, Braunschweig, Germany) was administered intravenously. Blood samples were obtained from the contralateral arm at eight time points over the course of 5 h. High-performance liquid chromatography (HPLC) on a Hitachi (Mannheim, Germany) HPLC system with a diode array detector was used. GFR was calculated with the area under the curve of plasma concentration versus time. Iohexol results were indexed for body surface area according to the DuBois-DuBois formula [19] .
Comparison of disease prevalence within BIS and AOKNordost
In order to analyse how representative our study population was compared to the insured of the AOK-Nordost of the same age, we compared the distribution of comorbidities within our BIS participants with the distribution of comorbidities within the AOK-Nordost population !70 years of age using the socalled hierarchical morbidity groups (HMGs) [20] . HMG diagnoses comprise different diseases grouped by severity, such as, for example, myocardial infarction, diabetes mellitus or osteoarthritis, and used by the insurance company to assess the disease burden of their insured. Motivated by our sampling scheme (stratified for age and gender), we directly standardized our data using the age/gender distribution in the total sample of the AOK-Nordost as a reference. Throughout the article, standardized proportions of HMGs are reported.
Statistical analysis
The aim of the analysis was to describe the cohort population, identify associations between main characteristics and outcome variables and detect characteristics that differed by age, gender and kidney function. Descriptive analyses include absolute and relative frequencies, means, standard deviations, medians and ranges. In the figures, box plots and locally weighted scatterplot smoothing approximations for curve fit were applied. HMG diagnoses and their analysis have been described in the previous paragraph. Differences between the study samples, i.e. the random and the advertisement sample were analysed using t-tests for normally distributed data, Mann-Whitney tests for not normally distributed data and chisquare tests for proportions. The raw and adjusted (age/gender) association of risk factors with reduced eGFR (eGFR BIS2 <60 mL/min/1.73 m 2 ) and macroalbuminuria (ACR !30 mg/g) were analysed using chi-square tests and multiple logistic regression analysis. To investigate the association of kidney function markers and eGFR (estimated with different formulae) with age, trend tests (ANOVA, chi-square) were applied. In these analyses, log transformed values for kidney function markers were used to obtain normally distributed data. No imputation for missing values was applied.
The comparison of different subsamples had not been planned in the published study protocol [9] , thus it has to be interpreted as an exploratory analysis. No primary scientific question was addressed and no correction for multiple testing was performed. The level of significance was 0.05 (two-sided). However, tests of significance are not strictly confirmatory as there was not one single predefined primary study hypothesis. Commercially available software (SPSS 22.0) was used.
R E S U L T S
Response rate and characteristics of recruitment samples Altogether, 16 701 invitation letters were randomly drawn and sent out in several waves. Of these, 1354 individuals completed the baseline visit (random sample) corresponding to an overall response rate of 8.1%. Stratified by age and gender, we observed a decrease from 12 (participants at age 70-75 years) to 6% (participants at age !90 years) in males, and from 11 to 2% in females, respectively (data not shown). Additionally, 715 elderly individuals answered the advertisement (advertisement sample), resulting in a total cohort of 2069 individuals. All 2069 had a completed computer-based questionnaire and physical examination, 2068 had a valid serum analysis and 2007 had a valid blood count analysis. Material for urine analysis was available for 2058 participants, leaving the proportion of missing information at <5% for any variable. Altogether, 25 of 2069 participants were visited at home due to frailty. Table 1 displays the total and age-specific baseline characteristics of the study cohort. The mean age was 80.4 years (median 80). Slightly more females (53%) participated. The majority was living with a partner (54%), received a monthly income between 1000 and e 2000 (61%) and had a low education level (60%). In terms of risk factors, approximately one-fifth enjoyed a daily alcoholic drink, half of the participants had either smoked at some point in their life or were still smoking and one-quarter was obese. The majority (79%) was on antihypertensive medication, one-quarter had diabetes, 9 and 14% had experienced a stroke or myocardial infarction, respectively, almost onequarter had cancer and almost one-fifth was anaemic. The mean office blood pressure was 146/81 mmHg. Apart from alcohol intake, diabetes, systolic blood pressure and C-reactive protein, all other variables showed statistically significant differences between the two age groups.
Main characteristics by age
Gender-specific analyses demonstrated that women were more likely to live alone and had a lower socio-economic status than men: they received less retirement pay and had lower professional qualifications. They had smoked and consumed considerably less alcohol in their life and were overall healthier than men, with a significantly lower prevalence of diabetes, myocardial infarction, cancer and anaemia (Supplementary data, Table S1 ).
Overall, participants in the advertisement sample were younger, which could be explained by the oversampling for older individuals in the random sample. They were more likely to be female, had less diabetes and demonstrated slightly lower creatinine and cystatin C values and less albuminuria compared with the random sample (Supplementary data, Table S2 ).
Representativeness of the BIS population
In order to find out how representative our study population was in relation to the AOK-Nordost insurance population of the same age, we compared the prevalence rates of HMGs in the BIS population and the entire AOK-Nordost insurance population !70 years of age. Figure 1 displays the comparison of different HMGs among men and women in the BIS population and the AOK-Nordost population !70 years of age, age and gender weighted. The comparison demonstrates very good agreement between the two populations, with no difference in prevalence rates being >6%.
Creatinine, cystatin C and ACR by age strata As demonstrated in the box plots of Figure 2A Kidney function markers and GFR estimating equations by age Table 4 lists the two biomarkers creatinine and cystatin C by age categories as well as different GFR equations based on these two markers. Clearly, participants had an increase in creatinine and cystatin C with increasing age corresponding to higher prevalences of eGFR <60 mL/min/1.73 m 2 . Also, the prevalence rates of individuals with an eGFR <60 mL/min/1.73 m 2 strongly depended on the equation used, with the highest prevalence rates yielded by the BIS1 (61.7%), Cockcroft-Gault (55.9%) and Lund-Malmö (55.3%) equations. Figure 3 shows the decrease of mean eGFR values by age (strata) in the iohexol subgroup (n ¼ 570) using mean GFR as a reference (the respective mean GFR values can be found in Supplementary data, Table S3 ; Supplementary data, Figure S1 demonstrates the same for the entire population). Both graphs show that the cut-off of 60 mL/min/1.73 m 2 is crossed at different age categories depending on the estimating equation.
D I S C U S S I O N
Within the scope of the BIS we were able to recruit 2069 older adults, of whom >1000 were octogenarians. Our data provide a unique collection of sociodemographic and lifestyle variables and comorbidities, as well as blood and urine measurements, for a comprehensive health assessment in a large elderly population-based cohort. With its particular orientation towards CKD the BIS also assessed measured GFR in a subsample of almost 600 participants, which is one of several unique features of the cohort.
Age-specific analyses demonstrated that the prevalence of most comorbidities was higher in octogenarians compared with individuals <80 years of age. This was particularly pronounced for anaemia and reduced GFR, which were present more than 2-fold in older age. Diabetes, diastolic blood pressure and BMI were not increased at older age. Reasons for that may be that individuals with diabetes have a higher fatality rate and (especially diastolic) blood pressure and BMI tend to decrease with [22, 23] . Gender-specific differences revealed that elderly women, despite their lower socio-economic status, demonstrated fewer risk factors and comorbidities than men. These differences were surprisingly high in the prevalence of anaemia, myocardial infarction and severe albuminuria, which were almost 2.5-fold higher in men compared with women.
More than half of the study participants exhibited reduced eGFR BIS2 . Applying the eGFR CKD-EPI equation led to a prevalence of 37.9%, which is in very good accordance with a prevalence of 37.8% from the National Health and Nutrition Examination Survey (NHANES) among those !70 years of age [24] and of 35.5% in a Canadian community-dwelling cohort study with a mean age of 76 years [25] , as well as a Finnish survey in elderly residents [26] . However, comparing data is challenging since cohort studies explicitly focusing on kidney function in older adults are rare, most studies still use nonenzymatic creatinine and no cystatin C at all and elderly participants often constitute only part, the 'upper end', of the population under study and are not the main focus. There are also remarkably few data about albuminuria in older age. We found the albuminuria rate of 26% (of which 3.6% was macroalbuminuria) in the BIS consistent with rates in the NHANES III population, where 21.2% presented with albuminuria at >70 years of age and 32.7% at >80 years, with similar distribution of micro-and macroalbuminuria [27] . The stratification of comorbidities into eGFR 60 and >60 mL/min/1.73 m 2 confirmed associations observed in another cross-sectional study of older adults [28] . The negative association between male sex and reduced GFR can most probably be explained by the fact that men had slightly better kidney function compared with women (Supplementary data, Table S1 ). GFR results strongly depended on the estimating equation. Differences as a function of the equation have been reported before [29] . However, the Lund-Malmö equation has never been included in such comparisons, although this equation was validated in a sample that included many elderly individuals. Our analysis focused less on equation performance in comparison to a gold standard. Rather, we felt that for a comprehensive analysis of kidney function in older adults, the most current equations, based on creatinine and/or cystatin C, should be demonstrated to increase awareness among clinicians about the strong differences in eGFR results.
Our cohort study has several strengths. It is a large population-based sample of truly older adults with detailed phenotyping and the opportunity to compare and complement our data with claims data. Laboratory analyses for creatinine and cystatin C are done using standardized assays, which is important for precise and unbiased measurements. Almost a third of the cohort has measured GFR, adding strength to the assessment of kidney function.
Some limitations deserve mention. First, the response rate of the random sample was only 8.1%. To test representativeness we rigorously compared the distribution of several comorbidities within the BIS and the AOK-Nordost population of the same age. We chose CKD, myocardial infarction and stroke, as they are main outcome variables of the BIS, and added other comorbidities that impact disease burden in older adults to shape a meaningful picture of our cohort in relation to its 'source population'. Against our expectations the cohort participants were not healthier compared with the AOK population. The AOK is both Germany's and Berlin's largest statutory health insurance company. For Berlin, coverage is almost 50% of individuals >70 years of age. We feel that this direct comparison of claims data justifies the notion that the BIS is a representative sample of the AOK, and maybe beyond. A second limitation is that we measured creatinine only once. Therefore we are unable to speak of true CKD, which requires repeat measurements. We will be able to report data about chronicity in the future, as the follow-up visits of the BIS are currently ongoing. Third, in a cross-sectional analysis we are unable to link cause and effect, thus the relation between kidney parameters (eGFR and albuminuria) and comorbidities are associations only. Lastly, our data include Caucasians only and cannot necessarily be extended to non-Caucasian populations.
In conclusion, the BIS is one of very few community-based cohorts of older adults with a main focus on kidney parameters. The study points out considerable age-and gender-specific differences in comorbidity prevalence rates as well as differences in eGFR values as a function of the estimating equation used. These data accentuate the distribution of reduced GFR and albuminuria in relation to other comorbidities in the older population. In addition, they contribute to the groundwork for future research on health development, patient-centred care and anticipation of health care expenditures in this growing field of geriatric nephrology.
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